RIA
VRCA icon

Realta Investment Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

Realta Investment Advisors’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40
Closed -$6K – 1367
2019
Q4 		$6K Buy
+40
New +$5.9K ﹤0.01% 1307
2019
Q3 		– Sell
-40
Closed -$5K – 1804
2019
Q2 		$5K Buy
+40
New +$3.75K ﹤0.01% 1392

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Realta Investment Advisors's VRCA Position: Q1 2020 in Review

Realta Investment Advisors sold out of Verrica Pharmaceuticals (VRCA) in Q1 2020, closing a stake of 40 shares — an estimated $6K sold.

Realta Investment Advisors first reported a position in VRCA in Q2 2019 and held it in 2 quarters. The position peaked at $6K in Q4 2019. 48 funds tracked by Wall St. Rank hold VRCA as of Q1 2020.

  • Realta Investment Advisors reported no remaining Verrica Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 40 Verrica Pharmaceuticals shares in Q1 2020, an estimated $6K.
  • Realta Investment Advisors first reported a position in Verrica Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Realta Investment Advisors's Verrica Pharmaceuticals position peaked at $6K in Q4 2019.
  • 48 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.